GB0412914D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0412914D0
GB0412914D0 GB0412914A GB0412914A GB0412914D0 GB 0412914 D0 GB0412914 D0 GB 0412914D0 GB 0412914 A GB0412914 A GB 0412914A GB 0412914 A GB0412914 A GB 0412914A GB 0412914 D0 GB0412914 D0 GB 0412914D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0412914A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxagen Ltd
Original Assignee
Oxagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxagen Ltd filed Critical Oxagen Ltd
Priority to GB0412914A priority Critical patent/GB0412914D0/en
Publication of GB0412914D0 publication Critical patent/GB0412914D0/en
Priority to PCT/GB2005/002242 priority patent/WO2005121141A1/en
Ceased legal-status Critical Current

Links

GB0412914A 2004-06-10 2004-06-10 Compounds Ceased GB0412914D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0412914A GB0412914D0 (en) 2004-06-10 2004-06-10 Compounds
PCT/GB2005/002242 WO2005121141A1 (en) 2004-06-10 2005-06-07 Pyrrolopyridine derivatives and use thereof for treating diseases mediated by prostaglandin d2 (pgd2)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0412914A GB0412914D0 (en) 2004-06-10 2004-06-10 Compounds

Publications (1)

Publication Number Publication Date
GB0412914D0 true GB0412914D0 (en) 2004-07-14

Family

ID=32732215

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0412914A Ceased GB0412914D0 (en) 2004-06-10 2004-06-10 Compounds

Country Status (2)

Country Link
GB (1) GB0412914D0 (en)
WO (1) WO2005121141A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY144903A (en) 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists
US7531568B2 (en) 2004-11-30 2009-05-12 Plexxikon, Inc. PPAR active compounds
AU2005311826A1 (en) * 2004-11-30 2006-06-08 Plexxikon, Inc. Indole derivatives for use as PPAR active compounds
GB0525143D0 (en) 2005-12-09 2006-01-18 Novartis Ag Organic compounds
PL2051962T3 (en) 2006-08-07 2012-03-30 Actelion Pharmaceuticals Ltd (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
CL2007003444A1 (en) * 2006-11-30 2008-06-27 Genentech Inc PIRROLO DERIVATIVE COMPOUNDS [3,2-C] PIRIDINE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF A HYPERPROLIFERATIVE DISORDER OR AN INFLAMMATORY DISEASE.
PE20090159A1 (en) 2007-03-08 2009-02-21 Plexxikon Inc INDOL-PROPIONIC ACID DERIVED COMPOUNDS AS PPARs MODULATORS
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
CN102791689B (en) 2010-03-22 2014-10-29 埃科特莱茵药品有限公司 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin D2 receptor modulators
US20130216552A1 (en) * 2010-07-12 2013-08-22 Ironwood Pharmaceuticals, Inc. Crth2 modulators
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
KR101928595B1 (en) 2011-04-14 2018-12-12 이도르시아 파마슈티컬스 리미티드 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
HUE039614T2 (en) 2014-03-17 2019-01-28 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators
ES2699379T3 (en) 2014-03-18 2019-02-11 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as modulators of the prostaglandin D2 receptor
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
ES2867757T3 (en) 2015-09-15 2021-10-20 Idorsia Pharmaceuticals Ltd Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201635D0 (en) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (en) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
CA2503767C (en) * 2002-10-30 2009-09-22 Merck Frosst Canada & Co./Merck Frosst Canada & Cie Pyridopyrrolizine and pyridoindolizine derivatives
SE0303180D0 (en) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
WO2005121141A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
EP1737831A4 (en) Neurologically-active compounds
GB0405937D0 (en) Compounds
GB0412914D0 (en) Compounds
EP1755617A4 (en) Perfluorocarbon-soluble compounds
GB0405193D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0404104D0 (en) Compounds
GB0403594D0 (en) Compounds
GB0405194D0 (en) Compounds
GB0405230D0 (en) Compounds
GB0405248D0 (en) Compounds
GB0405100D0 (en) Compounds
GB0405099D0 (en) Compounds
GB0404215D0 (en) Compounds
GB0406915D0 (en) Compounds
GB0404084D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)